Session Type
Meeting
Search Results for COVID-19
Abstract Number: 94
SHM Converge 2024
Background: Survivors of critical illness, such as acute respiratory distress syndrome (ARDS) requiring invasive mechanical ventilatory support in an intensive care unit (ICU), commonly experience prolonged morbidity in multiple health domains: psychological distress, functional debility, cognitive impairment, and poorer quality of life. This resulting morbidity is now recognized broadly as post-intensive care syndrome (PICS). COVID-19 ICU survivors are at […]
Abstract Number: 95
SHM Converge 2021
Background: Throughout the COVID-19 pandemic, the practice of intubation for hypoxemic respiratory failure secondary to presumed COVID ARDS has shifted from earlier to later intubation at our hospital. Patients are now intubated for respiratory fatigue rather than for only hypoxemia. Timing of intubation has not been associated with change in mortality based on one recent […]
Abstract Number: 96
SHM Converge 2021
Background: The COVID-19 RT-PCR test is a real-time reverse transcription polymerase chain reaction (rRT-PCR) test for the qualitative detection of nucleic acid from SARS-CoV-2 virus (8). False negative RT-PCR tests pose a serious challenge as they can lead to diagnosis and treatment delays as well as increased risk of viral transmission in the community (1-10). […]
Abstract Number: 99
SHM Converge 2021
Background: On March 7, New York was declared in “State of Emergency”; all Emergency Room and hospital facilities in NYC were overwhelmed by the rapid and high influx of patients with COVID-19 infection. At least 20% of patients with criteria for hospitalization received mechanical ventilation, and the Mortality reached 80% in a time when the […]
Abstract Number: A6
SHM Converge 2022
Background: Obesity increases the risk of severe illness, hospitalizations, and death from most acute illnesses – particularly infectious diseases. (1,2) African American communities have been greatly affected by the COVID-19 pandemic and are disproportionately impacted by the obesity epidemic in this country. (3, 4) However, little is known of their knowledge and attitudes related to […]
Abstract Number: A9
SHM Converge 2022
Background: Elevated proinflammatory cytokines, including IL-6, are associated with significant morbidity and mortality in COVID-19, and it is hypothesized that blocking the inflammatory pathway may prevent disease progression[1]. IL 6 inhibitors were proposed as a treatment option for hospitalized patients to improve patient-centered outcomes[1]. Few studies that investigated the safety of tocilizumab showed heterogeneous results[2,3]. […]
Abstract Number: B5
SHM Converge 2022
Background: Falls are the most common cause of nonfatal trauma-related hospital admissions among older adults. The objective of this study was to determine whether the quarantine/lockdown elicited by the SARS-CoV-2 pandemic led to a change in the incidence of falls in geriatric patients between March 2020 – December 2020 compared to March 2019 – December […]
Abstract Number: C1
SHM Converge 2022
Background: Obesity is associated with many cardiopulmonary comorbidities independently associated with worse health outcomes in acute illness, yet the physiological mechanisms potentially making obese patients more susceptible to COVID-19 remain uncertain. Adiposity-derived immunosuppression, increased thrombogenic potential, and predilection towards inflammatory hyperreactivity have all been postulated as potential mediators of this phenomenon. Yet, the most obvious […]
Abstract Number: C6
SHM Converge 2022
Background: The Coronavirus disease 2019 (COVID-19) pandemic caused a staggering 200 million cases with over 4 million deaths globally as of August 2021. COVID-19 is associated with lung inflammation and pulmonary fibrosis. Inhaled corticosteroids (ICS) are used to improve lung function by reducing inflammation, edema, mucus secretion, and inhibiting various cytokine activities. However, there is […]
Abstract Number: E2
SHM Converge 2022
Background: Evidence-based COVID-19 management has evolved with unprecedented speed; however, the rate and fidelity with which institutions have adopted new evidence into practice is unknown. Methods: We surveyed members of the Hospital Medicine Reengineering Network (HOMERuN) from 12/17/20-2/10/21 and compared their institutional COVID-19 management recommendations to available evidence from pivotal randomized controlled trials (RCTs) and […]